🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hepatopulmonary Syndrome - or is Portopulmonary hypertension? What’s the diff (brief #tweetorial) Pulm complications of #cirrhosis can be devastating. This month on rounds, I was reminded that these conditions are confusing. #meded

💡 Ever wondered why urine output isn’t part of HRS-AKI criteria per ICA but is in KDIGO? This thread explains it well! #LiverTwitter #CriticalCare

✨Celebrating the 35th anniversary of liver transplantation at the University Hospital Center in Zagreb! Obilježavanje 35 godina transplantacije jetre u KBC Zagreb youtu.be/jEcaQN0waFE?si… via YouTube

#LiverTwitter, exciting news! 🎉 My abstract has been accepted for #EASLCongress 2025 in Amsterdam, from 7-10 May. I hope to see you there – secure your spot now and let's revolutionise liver science together! 💡👩‍🔬 ctt.ec/PqUan+ @EASLNews

Applications Open! The ERN RARE-LIVER Clinical Exchange Programme offers clinicians & healthcare professionals the chance to specialise in rare liver diseases for up to 2 weeks 📅 Summer 2025 & 2026 📍 Open to ERN RARE-LIVER member centres 🔗 Apply now: rare-liver.eu/training-educa…

Original Article Corticosteroids in severe alcohol-associated hepatitis? Not so fast: A systematic review of randomized controlled trials Shi, Pungwe et al. #LiverX tinyurl.com/mzzk8uar

🧬 Što je autoimuni hepatitis? 🩺 Kako se dijagnosticira i liječi? Saznajte više na online predavanju za pacijente i obitelj. 📅 29.4.2025. u 18 h 👩‍⚕️ dr. sc. Maja Sremac, KBC Zagreb 🔗 rijetkebolestijetre.hr #autoimunihepatitis #rijetkebolestijetre #hepatologija

💊 Beta Blockers in Cirrhosis

Futility in liver transplantation is such a complex topic that continues to spark daily discussions. The release of the first guidelines on futility is a crucial step in providing clarity and direction for future work. Kudos to INASL and thank you Akash Roy for sharing!

🤩

Still reflecting on yesterday’s powerful ESOTtransplant Journal Club 💭 Antimicrobial resistance in SOT is no longer emerging—it's here. 🔍 Must-read review in Transplant International: New antibiotics for MDR GNB in LTx – clinical insights, PK/PD & toxicity 🔗 doi.org/10.3389/ti.202…

💬 on a✈️ to 📝 with Anand V Kulkarni 🔸So we all 🗣️AKI in CLD 🔸But ⁉️ESRD with ascites on consults (and they aren't uncommon) 🔸We dig deep -SAAG 🚫 -Causes: Mixed bag -Nephrogenic ascites 📈 ☠️ - 💊❓ Large gaps in 📝 Elliot Tapper Liver Fellow Network AASLD journals.lww.com/hepcomm/fullte…

Portal sinusoidal vascular diseases: Assessment and therapy. 🔓HEPATOLOGY Journal acortar.link/ieygKU #PSVD #LiverTwitter #OpenAccess

🧬🔬❗️

Touch up on your acute on chronic liver failure management. From definitions to pathophysiology to treatment, this review has what you need to know. 🎩 Tips to the authors. eddyjoemd.com/foamed

Kicking off #EASL2025 with our poster on HCV microelimination in Croatian prisons! Civil society-led, mobile, and linked-to-care: The Hepatos Project is reaching where care is most needed. #EASL2025 #EASLcongress EASLnews

📃5 new EASL CPGs released today at #EASLCongress! 👉Make sure to attend the much awaited sessions listed below! Access the publications: 📃 EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease